Pharma-Bio Serv (PBSV) Return on Equity (2011 - 2026)

Pharma-Bio Serv's Return on Equity history runs 14 years deep, the most recent figure standing at 0.0% for Q2 2026.

• Return on Equity for Q2 2026 came in at 0.0%, changed 0.0% year-over-year; the trailing twelve-month figure through Apr 2026 was 0.0% (changed 0.0% YoY), and the FY2025 annual result was 0.0%, changed 0.0% from the prior year.
• Return on Equity came in at 0.0% for Q2 2026 at Pharma-Bio Serv, up from 0.0% in the prior quarter.
• In the past five years, Return on Equity ranged from a high of 0.0% in Q3 2023 to a low of 0.0% in Q3 2022.
• A 5-year average of 0.0% and a median of 0.0% in 2025 frame the typical range for Return on Equity.
• The largest YoY upside for Return on Equity was 0 bps in 2022 against a maximum downside of 0 bps in 2022.
• Over 5 years, Return on Equity stood at 0.0% in 2022, then soared by 32 bps to 0.0% in 2023, then sank by 170 bps to 0.0% in 2024, then surged by 84 bps to 0.0% in 2025, then soared by 154 bps to 0.0% in 2026.
• The last three Return on Equity figures came in at 0.0% (Q2 2026), 0.0% (Q1 2026), and 0.0% (Q4 2025), per Business Quant data.